Atlas Trials

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

Clinical trial NCT01397422 · COMPLETED

Trial details

NCT number
NCT01397422
Sponsor
Adamas Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
DyskinesiaLevodopa Induced DyskinesiaParkinson's Disease
Start date
2011-07-01
Primary completion
2013-05-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.